loading
Schlusskurs vom Vortag:
$112.56
Offen:
$113.28
24-Stunden-Volumen:
106.50K
Relative Volume:
0.91
Marktkapitalisierung:
$2.19B
Einnahmen:
$152.42M
Nettoeinkommen (Verlust:
$45.24M
KGV:
45.28
EPS:
2.51
Netto-Cashflow:
$6.97M
1W Leistung:
-1.78%
1M Leistung:
+11.83%
6M Leistung:
+4.83%
1J Leistung:
+34.05%
1-Tages-Spanne:
Value
$111.72
$114.68
1-Wochen-Bereich:
Value
$111.72
$116.61
52-Wochen-Spanne:
Value
$81.74
$129.90

Ligand Pharmaceuticals Inc Stock (LGND) Company Profile

Name
Firmenname
Ligand Pharmaceuticals Inc
Name
Telefon
858-550-7500
Name
Adresse
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
Name
Mitarbeiter
68
Name
Twitter
@Ligand_LGND
Name
Nächster Verdiensttermin
2025-02-18
Name
Neueste SEC-Einreichungen
Name
LGND's Discussions on Twitter

Vergleichen Sie LGND mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LGND
Ligand Pharmaceuticals Inc
113.66 2.19B 152.42M 45.24M 6.97M 2.51
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Ligand Pharmaceuticals Inc Stock (LGND) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-10 Eingeleitet Stifel Buy
2024-10-03 Eingeleitet Oppenheimer Outperform
2024-07-30 Eingeleitet RBC Capital Mkts Outperform
2021-04-14 Fortgesetzt Stephens Overweight
2021-02-04 Bestätigt H.C. Wainwright Buy
2020-10-06 Eingeleitet Barclays Overweight
2020-03-24 Herabstufung Argus Buy → Hold
2020-03-10 Eingeleitet Guggenheim Neutral
2020-02-06 Eingeleitet The Benchmark Company Buy
2019-09-19 Hochstufung Barclays Equal Weight → Overweight
2019-06-11 Eingeleitet Barclays Equal Weight
2019-05-03 Bestätigt H.C. Wainwright Buy
2019-03-06 Bestätigt H.C. Wainwright Buy
2018-10-29 Hochstufung ROTH Capital Neutral → Buy
2018-10-02 Bestätigt H.C. Wainwright Buy
2018-09-11 Bestätigt Argus Buy
2018-08-17 Eingeleitet Goldman Neutral
2018-08-08 Herabstufung ROTH Capital Buy → Neutral
2018-06-21 Eingeleitet Argus Buy
2017-12-27 Bestätigt H.C. Wainwright Buy
2017-09-05 Fortgesetzt H.C. Wainwright Buy
2016-10-05 Bestätigt H.C. Wainwright Buy
2016-08-05 Herabstufung Deutsche Bank Hold → Sell
2016-03-11 Eingeleitet Sidoti Buy
2016-03-03 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Ligand Pharmaceuticals Inc Aktie (LGND) Neueste Nachrichten

pulisher
Jun 16, 2025

Handelsbanken Fonder AB Has $700,000 Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Wealth Enhancement Advisory Services LLC Takes $286,000 Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

Cutaneous T-cell Lymphoma Market on Track for Major Expansion by 2034, According to DelveInsight | Innate Pharma, Galderma R&D, Kyowa Kirin, Citius Pharma, Soligenix, 4SC AG, oligenix, Ligand Pharma - Barchart.com

Jun 14, 2025
pulisher
Jun 13, 2025

Rhumbline Advisers Has $6.04 Million Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Ligand Pharmaceuticals CLO Andrew Reardon sells $57,270 in shares - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Ligand Pharmaceuticals CLO Andrew Reardon sells $57,270 in shares By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 11, 2025

3 Companies That May Be Trading Below Their Estimated Value - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Ligand Announces 2025 Investor Day in New York City | LGND Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Ligand Pharmaceuticals to Host Investor Day in New York City on December 9, 2025 - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Ligand Announces 2025 Investor Day in New York City - Bluefield Daily Telegraph

Jun 11, 2025
pulisher
Jun 10, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

GAMMA Investing LLC Purchases 61,996 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Jun 10, 2025
pulisher
Jun 05, 2025

Ligand Pharmaceuticals Incorporated to Host Earnings Call - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 03, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ligand Pharmaceuticals Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017LGND - ACCESS Newswire

Jun 03, 2025
pulisher
May 29, 2025

BNP Paribas Financial Markets Cuts Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 29, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Sells 1,507 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 26, 2025
pulisher
May 26, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 26, 2025
pulisher
May 23, 2025

Bank of America Corp DE Purchases 2,533 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 23, 2025
pulisher
May 21, 2025

Executives At Ligand Pharmaceuticals Show Confidence With Major Stock Buys - Finimize

May 21, 2025
pulisher
May 20, 2025

Jane Street Group LLC Sells 1,083 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 20, 2025
pulisher
May 20, 2025

Ameriprise Financial Inc. Raises Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 20, 2025
pulisher
May 19, 2025

Ligand Rings the Nasdaq Stock Market Opening Bell - Nasdaq

May 19, 2025
pulisher
May 16, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 16, 2025
pulisher
May 14, 2025

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - TradingView

May 14, 2025
pulisher
May 14, 2025

The Manufacturers Life Insurance Company Buys 779 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

May 14, 2025
pulisher
May 13, 2025

Ligand Pharmaceuticals Executives Increase Holdings - TradingView

May 13, 2025
pulisher
May 13, 2025

Ligand Pharmaceuticals (NASDAQ:LGND) Downgraded to Sell Rating by StockNews.com - Defense World

May 13, 2025
pulisher
May 12, 2025

LGND: 1Q:25 Results - MSN

May 12, 2025
pulisher
May 11, 2025

Ligand Pharmaceuticals First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 11, 2025
pulisher
May 10, 2025

Oppenheimer Maintains Rating and Raises Price Target for LGND | - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 09, 2025

Oppenheimer Maintains Rating and Raises Price Target for LGND | LGND Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Oppenheimer Raises Price Target for Ligand (LGND) to $145 | LGND Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Oppenheimer Adjusts Ligand Pharmaceuticals Price Target to $145 From $142, Maintains Outperform Rating - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Ligand Pharmaceuticals Inc (LGND) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Ligand Pharmaceuticals Inc (LGND) Q1 2025 Earnings Call Highligh - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Earnings call transcript: Ligand Pharmaceuticals beats Q1 2025 expectations - Investing.com

May 09, 2025
pulisher
May 09, 2025

Ligand Pharmaceuticals Reports Strong Q1 2025 Revenue Growth - TipRanks

May 09, 2025
pulisher
May 08, 2025

Ligand Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks

May 08, 2025
pulisher
May 08, 2025

Ligand: Q1 Earnings Snapshot - Huron Daily Tribune

May 08, 2025
pulisher
May 08, 2025

Earnings call transcript: Ligand Pharmaceuticals beats Q1 2025 expectations By Investing.com - Investing.com UK

May 08, 2025
pulisher
May 08, 2025

Ligand Pharmaceuticals Q1 Core Adjusted Earnings, Revenue Increase; Shares Up Pre-Bell - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Ligand (LGND) Upholds 2025 Financial Guidance | LGND Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Ligand Pharmaceuticals Reports Q1 Revenue of $45.3M, Beating Estimates; EPS Falls Short with $2.21 Loss - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Ligand (LGND) Exceeds Revenue Expectations with Strategic Moves - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Ligand (LGND) Exceeds Revenue Expectations with Strategic Moves | LGND Stock News - GuruFocus

May 08, 2025

Finanzdaten der Ligand Pharmaceuticals Inc-Aktie (LGND)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):